Hiroki Kumagai

Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists.

M. Isogaya, Ryoji Hayashi, E. Ohmori, 2015, Bioorganic & medicinal chemistry letters.

Design and synthesis of selective alpha1B adrenoceptor antagonists.

M. Isogaya, Ryoji Hayashi, E. Ohmori, 2006, Bioorganic & medicinal chemistry letters.

Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors.

H. Fujii, Mikiya Satoh, H. Kawai, 2012, Bioorganic & medicinal chemistry letters.

(3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Kozono, H. Fujii, Mikiya Satoh, 2008, Bioorganic & medicinal chemistry letters.

HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models

S. Okazaki, Takehiro Takahashi, K. Kawai, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin I2 Analogue) in the Atherosclerotic Rabbit Artery After Angioplasty

S. Okazaki, S. Nishio, Y. Ueno, 1995, Journal of cardiovascular pharmacology.

HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models

S. Okazaki, M. Kainoh, Takehiro Takahashi, 2014, The Journal of Pharmacology and Experimental Therapeutics.